- Home
- SPKL vs INBX Comparison
SPKL vs INBX Comparison
Compare SPKL & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPKL
- INBX
- Stock Information
- Founded
- SPKL 2021
- INBX 2010
- Country
- SPKL United States
- INBX United States
- Employees
- SPKL N/A
- INBX N/A
- Industry
- SPKL
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- SPKL
- INBX Health Care
- Exchange
- SPKL Nasdaq
- INBX Nasdaq
- Market Cap
- SPKL 170.5M
- INBX 237.5M
- IPO Year
- SPKL 2023
- INBX 2020
- Fundamental
- Price
- SPKL $10.49
- INBX $16.99
- Analyst Decision
- SPKL
- INBX Hold
- Analyst Count
- SPKL 0
- INBX 1
- Target Price
- SPKL N/A
- INBX N/A
- AVG Volume (30 Days)
- SPKL 28.2K
- INBX 121.0K
- Earning Date
- SPKL 01-01-0001
- INBX 08-13-2024
- Dividend Yield
- SPKL N/A
- INBX N/A
- EPS Growth
- SPKL N/A
- INBX N/A
- EPS
- SPKL 0.12
- INBX 118.83
- Revenue
- SPKL N/A
- INBX $1,687,000.00
- Revenue This Year
- SPKL N/A
- INBX N/A
- Revenue Next Year
- SPKL N/A
- INBX N/A
- P/E Ratio
- SPKL $85.99
- INBX $0.14
- Revenue Growth
- SPKL N/A
- INBX 24.26
- 52 Week Low
- SPKL $10.07
- INBX $10.80
- 52 Week High
- SPKL $11.35
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- SPKL 69.74
- INBX 68.74
- Support Level
- SPKL $10.45
- INBX $14.51
- Resistance Level
- SPKL $10.49
- INBX $17.79
- Average True Range (ATR)
- SPKL 0.01
- INBX 0.84
- MACD
- SPKL 0.00
- INBX 0.23
- Stochastic Oscillator
- SPKL 80.20
- INBX 79.43
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.